Biopol Chemicals Limited (NSE:BIOPOL)

Biopol Chemicals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024
Period Ending	Mar 31, 2025	Mar 31, 2024
Net Income	43.3	12.81
Depreciation & Amortization	0.7	0.4
Other Amortization	0.01	0.01
Other Operating Activities	16.64	4.25
Change in Accounts Receivable	-65.25	-61.58
Change in Inventory	-56.81	-61.33
Change in Accounts Payable	47.21	19.44
Change in Other Net Operating Assets	-9.16	-2.71
Operating Cash Flow	-23.37	-88.72
Capital Expenditures	-0.25	-0.71
Sale of Property, Plant & Equipment	-	0
Investing Cash Flow	-0.25	-0.71
Short-Term Debt Issued	34.79	35.77
Long-Term Debt Issued	6.3	-
Total Debt Issued	41.09	35.77
Net Debt Issued (Repaid)	41.09	35.77
Issuance of Common Stock	-	55.73
Other Financing Activities	-6.82	-1.24
Financing Cash Flow	34.27	90.25
Net Cash Flow	10.66	0.82
Free Cash Flow	-23.61	-89.43
Free Cash Flow Margin	-4.81%	-51.30%
Free Cash Flow Per Share	-2.98	-
Cash Interest Paid	5.05	0.81
Cash Income Tax Paid	4.83	1.32
Levered Free Cash Flow	-36.4	-
Unlevered Free Cash Flow	-33.24	-
Change in Working Capital	-84.02	-106.18

Source: S&P Global Market Intelligence. Standard template. Financial Sources.